Showing results (391-400 of 612) with videos related to

Sort By:
Pageof 62
Multiple Sclerosis Journal - Experimental, Translational and Clinical|September 7, 2018
Pain in AQP4-IgG-positive and MOG-IgG-positive neuromyelitis optica spectrum disordersSusanna Asseyer, Felix Schmidt, Claudia Chien, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 18, 2018
Differences in clinical features between optic neuritis in neuromyelitis optica spectrum disorders and in multiple sclerosisJindapa Srikajon, Sasitorn Siritho, Chanon Ngamsombat, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 18, 2018
Reference videos reduce variability of motor dysfunction assessments in multiple sclerosisMarcus D'Souza, Saskia Steinheimer, Jonas Dorn, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 21, 2019
Efficacy and safety of dimethyl fumarate in treatment-naïve Japanese patients with multiple sclerosis: Interim analysis of the randomized placebo-controlled studyMasahiro Mori, Takashi Ohashi, Yasuhiro Onizuka, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|October 7, 2021
Do internet resources align with exercise training and physical activity guidelines for people with multiple sclerosis?Dena Sadeghi-Bahmani, Stephanie L Silveira, Jessica F Baird, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|May 10, 2019
Multicentre assessment of motor and sensory evoked potentials in multiple sclerosis: reliability and implications for clinical trialsMartin Hardmeier, François Jacques, Philipp Albrecht, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 22, 2019
No differential gene expression for CD4+ T cells of MS patients and healthy controlsIna S Brorson, Anna Eriksson, Ingvild S Leikfoss, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|April 14, 2023
Preserved T cell but attenuated antibody response in MS patients on fingolimod and ocrelizumab following 2nd and 3rd SARS-CoV-2 mRNA vaccineSarah Conway, Shrishti Saxena, Clare Baecher-Allan, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|April 2, 2021
Switching treatments in clinically stable relapsing remitting multiple sclerosis patients planning for pregnancyLubna Almouzain, Fiona Stevenson, Declan Chard, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|May 1, 2023
Mortality of multiple sclerosis in Iceland population-based mortality of MS in incidence and prevalence cohortsOlöf Eliasdottir, Ólafur Kjartansson, Elias Olafsson
Pageof 62